Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults.
Buddy Creech C, Jimenez-Truque N, Kown N, Sokolow K, Brady EJ, Yoder S, Solovay K, Rubin K, Noviello S, Hensel E, Selamawi S, Bakare A, Makowski M, Lu K.
Buddy Creech C, et al. Among authors: hensel e.
Vaccine. 2022 Nov 8;40(47):6740-6746. doi: 10.1016/j.vaccine.2022.09.075. Epub 2022 Oct 8.
Vaccine. 2022.
PMID: 36220716
Clinical Trial.